This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sahai A et al. (2006) Botulinum toxin-A is safe and effective in the treatment of patients with overactive bladder and idiopathic detrusor overactivity: Results from a randomised, double blind, placebo controlled trial [abstract #381]. Eur Urol 5: 118
Smith CP and Chancellor MB (2005) Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection. J Endourol 19: 880–882
Sahai A et al. (2006) Urodynamic assessment of poor responders following intra-detrusor injections of botulinum toxin A for overactive bladder [abstract]. J Endourol 20 (Suppl 1): A60
Acknowledgements
The synopsis was written by Tamsin Osborne, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors are investigators for Allergan, Ltd from whom they have received an unrestricted educational grant and free botulinum toxin for use in clinical trials. They are also supported by project grants from the British Urological Foundation and the Multiple Sclerosis Society.
Rights and permissions
About this article
Cite this article
Sahai, A., Dasgupta, P. & Khan, M. Is botulinum A toxin an effective treatment for idiopathic detrusor overactivity and sensory urgency?. Nat Rev Urol 4, 136–137 (2007). https://doi.org/10.1038/ncpuro0732
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0732